Founder : See Below
Location : Austin, TX
Target : $10,000,000
Share Type : Common StockBusiness Overview
- The Company (HPS) was formed in 2015, to take advantage of a significant opportunity in the population health and chronic disease management marketplace. HPS will introduce best-in-class technology based products to greatly decrease enterprise cost while improving health outcomes. HPS has cultivated best-in-class partnerships integrated into one seamless delivery and distribution platform. HPS is led by a seasoned and well connected management team with proven results which will utilize long-term existing relationships paired with a strong consulting business to rapidly scale the HPS growth.
Transaction Overview
- HPS is seeking $10M in the form of common stock in order to secure the Sherlock AI license, develop proprietary software, expand marketing / sales efforts, operations, and infrastructure development.
Investment Highlight
- Competitive Advantage: HPS is positioned to provide best-in-class, technology-based support for Population Health and Chronic Disease Management solutions. This will be accomplished through the integration of a comprehensive digital health platform, medical and fitness wearables, virtual care/telehealth devices and pharmaceutical grade nutritional supplements, powered by the AI engine Sherlock. HPS proprietary software will be designed to integrate the devices, products, platform components, and AI seamlessly to allow aggregated data flow from all sources along with high-level data analytics.
- Revenue Model: The platform components are sold using a subscription model along with license, support and consulting/integration fees. Devices and supplements are sold using a wholesale/retail model. Gross margins range from 40-60% depending on the product or service being delivered.
- Go to Market Strategy: HPS will utilize existing relationships to create immediate traction. HPS will focus on 3 channel prospects: Healthcare Providers/Systems, Payers, and Population Health companies.
- Pipeline: HPS has a qualified pipeline featuring leading population health management companies, health insurance companies, hospital systems, general insurance companies, corporate wellness companies and discount benefits providers. These companies represent over 180M lives in the U.S. alone.
- Leverage existing relationships and current prospects - Focus on channel prospects with large and urgent problems - Employ solutions-based consultative sales process - Partner with organizations with market/product synergy to jointly close large prospects
About Management Team
- Loren, CEO: Over 25 years of executive leadership in Population Health Management. Founder and CEO of Health Fitness Corporation, the world leader in Corporate Health and Wellness, which he took public on the NASDAQ stock exchange.
- Paul, CTO: Over 20 years of experience in Military Intelligence and Financial technology on Wall Street and City of London.
- Jeffrey, PhD, CSO: Nationally recognized expert in Population Health Management with over 25 years of experience in Healthcare and Enterprise consulting.
- Justin, Operations: Has an extensive background in innovative primary care delivery models, including patient centered medical home and direct primary care.
About Our Product
- HPS offers 4 distinct product groups, devices, supplements, digital platform, and the license for the AI engine Sherlock. These products are offered as a PaaS (Platform as a Service).
- For devices, HPS has an exclusive relationship with a fitness and medical wearables manufacturer, Vigor Medical Technologies, to produce private label wearable devices for its customers. These wearables are comparable to other devices on the market such as FitBit and Garmin, but at a fraction of the cost. HPS also offers a device through a relationship with MedSign, which provides access to virtual care management and telehealth services through the television, iOS, and/or Android devices. This device can provide health, wellness, safety, and security services for consumers.
- HPS has a relationship with a pharmaceutical grade supplement company, Thorne Research to offer their products through the HPS platform. Thorne supplements are innovative, high quality, and research based. Supplements can either be offered under the Thorne label or private labeled.
- The HPS platform is a flexible and customizable, mobile platform, which integrates the various products, devices, and services offered through HPS. In addition, the HPS platform has 35 health and wellness plugins to chose from to create a truly robust and integrated wellness portal for the consumer through a single, seamless experience.
- Sherlock, the AI engine, powers the HPS platform. Sherlock is modelled on the way that a human brain works; it combines self-learning techniques as well as the ability to reason. This allows the HPS Platform to increase efficiency, decrease costs and improve outcomes for its clients.
About Industry
- Over the next five years, healthcare will grow significantly. Mobile Health will increase from $24.3B to $84.4B. The Population Health Management market is predicted to increase from $8.3B to $26.4B, Healthcare Analytics increase $4.4B to $21.3B. By 2020 healthcare expenditures will total of $3.207 TRILLION which correlates to $10,000 per person. By 2020 20% of the USA’s GDP will be spent on healthcare.
Financials
Available on further discussion with registered investors.
About Competitor
- HPS believes that there are two categories of competitors: 1) Consulting and large SaaS providers and 2) Population health/chronic disease management providers. Most competitors are either very small or very large organizations. There are currently thousands of independent, non-integrated healthcare apps used and growing rapidly, none with a comprehensive solution.
Exit Strategy
- The Company is focused on a liquidity event with the next 4 years, either IPO or acquisition by a major insurance company, medical provider system or population health company.
Risk Warnings
Disclosure: Investing in startups carries a high degree of risk. In general, financial and operating risks confronting both early and developmental-stage companies, as well as more mature expansion-stage companies are significant. Many emerging growth companies go out of businesses every year. It is difficult to know how companies will grow, if at all, or what changes may occur in the market. A loss of an investors entire investment is possible and no profit may be realized. Investors are responsible for conducting their own due diligence.
* It should not be assumed that recommendations made in the future will be profitable or will equal the performance of securities in this list
- HPS offers 4 distinct product groups, devices, supplements, digital platform, and the license for the AI engine Sherlock. These products are offered as a PaaS (Platform as a Service).
- For devices, HPS has an exclusive relationship with a fitness and medical wearables manufacturer, Vigor Medical Technologies, to produce private label wearable devices for its customers. These wearables are comparable to other devices on the market such as FitBit and Garmin, but at a fraction of the cost. HPS also offers a device through a relationship with MedSign, which provides access to virtual care management and telehealth services through the television, iOS, and/or Android devices. This device can provide health, wellness, safety, and security services for consumers.
- HPS has a relationship with a pharmaceutical grade supplement company, Thorne Research to offer their products through the HPS platform. Thorne supplements are innovative, high quality, and research based. Supplements can either be offered under the Thorne label or private labeled.
- The HPS platform is a flexible and customizable, mobile platform, which integrates the various products, devices, and services offered through HPS. In addition, the HPS platform has 35 health and wellness plugins to chose from to create a truly robust and integrated wellness portal for the consumer through a single, seamless experience.
- Sherlock, the AI engine, powers the HPS platform. Sherlock is modelled on the way that a human brain works; it combines self-learning techniques as well as the ability to reason. This allows the HPS Platform to increase efficiency, decrease costs and improve outcomes for its clients.
This section of information is for our registered investor only. Please Sign Up as a Shanghai Valley investor.
This section of information is for our registered investor only. Please Sign Up as a Shanghai Valley investor.
This section of information is for our registered investor only. Please Sign Up as a Shanghai Valley investor.
This section of information is for our registered investor only. Please Sign Up as a Shanghai Valley investor.